The Digest is coming to you a day early as we are out tomorrow. I will send an update on Monday with any important information from Friday or the weekend.
New this week: Congress is back and doctors are stirring. CMS drops the Inpatient Rule and hospitals are furious, MedPAC is back and feeling contemplative. All this and more as we continue the “April showers with quite a few flowers (and pollen)” portion of springtime in DC.
The regulatory update for this week features finalized payment policies for Medicare Advantage and Part D programs, alongside ongoing negotiations with pharmaceutical companies. Additionally, the FDA approves Abbott’s TriClip™ device for repairing leaky tricuspid heart valves amidst a Senate hearing addressing concerns about private equity’s impact on healthcare.
With Congress out for a spring holiday, CMS decided to release some of the early Medicare rules and DC enjoyed one of the longest cherry blossom seasons on record (https://wapo.st/4cFlGLh)
As the end of Q1 fast approaches, we may finally have a funding deal… for this year. But do we have a Speaker?
This week featured publication of the long-awaited EtO Final Rule, more fallout from the Change Healthcare cyberattack, and PBM reform may not be dead…yet.
This week we focus on prescription drugs and the State of the Union while Change Healthcare’s outage continues on.
This week all eyes have been on Congress and their efforts to avert a partial (or total) government shutdown. Meanwhile, the EtO final rule (expected today) is still pending but the MA final rule is at OMB.
This week’s feature is my conversation with Peggy Tighe from Powers Law about the future of the Prior Auth Bill.
A conversation with Peggy Tighe, Principal, Powers Law
Copyright © 2022-2024 Savage Health Policy, LLC.
All rights reserved.
Recent Comments